CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in NSCLC
Horne, Ashley Brown, S Coyle, V. Franks, K. Hassani, A. Harrow, S. Hatton, M. Hiley, C. Kendall, J. Oughton, J.
Horne, Ashley
Brown, S
Coyle, V.
Franks, K.
Hassani, A.
Harrow, S.
Hatton, M.
Hiley, C.
Kendall, J.
Oughton, J.
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2023
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Horne A, Brown S, Coyle V, Franks K, Hassani A, Harrow S, et al. CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in NSCLC. Lung cancer (Amsterdam, Netherlands). 2023 Apr;178:S86-S7. PubMed PMID: WOS:000995413600195.